We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.30 | -0.88% | 33.70 | 33.70 | 33.85 | 34.30 | 33.45 | 34.30 | 811,749 | 16:35:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 200.00 | 183.65M |
TIDMAPH
RNS Number : 9808Q
Alliance Pharma PLC
23 June 2015
For immediate release 23 June 2015
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Director Shareholding
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was notified on 23 June 2015 that on 23 June 2015, Lynette Booley, spouse of Anthony Booley, an-Executive Director of the Company, sold 1,000,000 ordinary shares of 1 pence in the Company ("Ordinary Shares") at a price of 37.0 pence per share, and Anthony Booley sold 1,155,000 Ordinary Shares on the same date at the same price.
Following this transaction, Mr Booley's total beneficial interest in the Company is 2,055,723 Ordinary Shares, representing approximately 0.78% of the Company's issued share capital.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966 John Dawson, Chief Executive www.alliancepharma.co.uk + 44 (0) 20 7466 Buchanan 5000 Mark Court / Sophie Cowles / Jane Glover + 44 (0) 20 7260 Numis Securities Limited 1000 Nominated Adviser: Michael Meade / Freddie Barnfield Corporate Broking: David Poutney
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSFJMTTMBBTBAA
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions